Finnish Defence Forces
Hämeenlinna, 13210, Finland
NCT Number: NCT05014048
Vitamin D intervention effects on the prevention of acute respiratory tract infections among Young Finnish Men
Looking for future studies?
Notify Me18 year–29 year
Male
Interventional
Not applicable
Hämeenlinna, 13210, Finland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
;
Exclusion criteria
20 mikrog vitamin D3 daily
Placebo
Time frame: 4 months
The number of Days off Duty recommended by Health care personnel will be calculated in order to show the severity and last of the disease. By that it could be estimated how the disease will effect on duty service.
Time frame: 4 months
The number of days off Duty because of musculoskeletal disorders will be index for outcome. The index will be compared between plasebo and intervention group
Time frame: 4 months
Used test are Cooper-test for aerobic and Finnish military fitness test for muscular fitness performance. The index will be compared between plasebo and intervention group
Tampere University
Other
Vitamin D Supplementation for the Prevention of Acute Respiratory Tract Infection: a Randomized, Double-blinded and Plasebo Controlled Trial Among Young Finnish Men
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04170348
Acute Chest Syndrome, Anemia
New York, United States
View Trial DetailsNCT01443728
Acute Chest Syndrome, Anemia
New York, United States
View Trial DetailsNCT01549938
Avitaminosis, Deficiency Diseases
Hobart, Tasmania, Australia
View Trial DetailsNCT07631312
Anemia, Anemia, Hypochromic
Atlanta, Georgia, United States
View Trial Details